Stock Research: Sawai Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Sawai Pharmaceutical

TSE:4555 JP3323040000
70
  • Value
    55
  • Growth
    52
  • Safety
    Safety
    86
  • Combined
    80
  • Sentiment
    39
  • 360° View
    360° View
    70
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Sawai Group Holdings Co Ltd manufactures and sells medical and over-the-counter drugs. They operate in pharmaceutical and medical device manufacturing and sales, and R&D. Key regions include Japan and America. In the last fiscal year, the company had 3310 employees, a market cap of $1489 million, profits of $376 million, and revenue of $1261 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 70 (better than 70% compared with alternatives), overall professional sentiment and financial characteristics for the stock Sawai Pharmaceutical are above average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for Sawai Pharmaceutical. The consolidated Value Rank has an attractive rank of 86, which means that the share price of Sawai Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 86% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 52, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 55. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 39. Professional investors are more confident in 61% other stocks. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
86 86 92 100
Growth
52 59 39 51
Safety
Safety
55 61 72 70
Sentiment
39 86 82 25
360° View
360° View
70 98 98 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
47 40 44 28
Opinions Change
50 70 82 50
Pro Holdings
n/a 92 82 39
Market Pulse
75 65 54 44
Sentiment
39 86 82 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
86 86 92 100
Growth
52 59 39 51
Safety Safety
55 61 72 70
Combined
80 86 92 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
77 81 74 97
Price vs. Earnings (P/E)
76 76 91 97
Price vs. Book (P/B)
64 78 71 93
Dividend Yield
74 65 82 92
Value
86 86 92 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
53 36 37 43
Profit Growth
21 79 50 81
Capital Growth
64 34 18 24
Stock Returns
62 74 77 49
Growth
52 59 39 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
23 27 33 36
Refinancing
80 76 89 89
Liquidity
57 59 59 53
Safety Safety
55 61 72 70

Similar Stocks

Discover high‑ranked alternatives to Sawai Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Tokuyama

TSE:4043
Country: Japan
Industry: Specialty Chemicals
Size: Medium
Full Stock Analysis

Kumagai Gumi

TSE:1861
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Aeon Delight

TSE:9787
Country: Japan
Industry: Facility Services
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.